Preclinical development of AIC-649 as a new strategy for the treatment of chronic viral infections Jan. 10, 2014
Cenicriviroc, a dual CCR2/CCR5 inhibitor, as novel therapeutic strategy for liver fibrosis Jan. 8, 2014
Researchers from Curis present preliminary results of a first-in-human trial of CUDC-907 Jan. 7, 2014